Abstract
The activity of the new streptogramin RP 59500 in vitro was determined against 380 strains of anaerobic bacteria by an agar dilution method and compared with that of pyostacine, piperacillin, cefoxitin, imipenem, clindamycin, metronidazole and chloramphenicol. RP 59500 and imipenem were the most active agents tested. On the basis of these results, RP 59500 appears to be a promising antimicrobial agent for treatment of anaerobic infections, further clinical investigations being warranted.
Similar content being viewed by others
References
Holdeman, L. V., Cato, E. P., Moore, W. E. C. Anaerobe laboratory manual. Virginia Polytechnic Institute and State University, Blacksburg, PA, 1977.
Dornbusch, K., Nord, C. E., Olsson-Liljequist, B. Antibiotic susceptibility of anaerobic bacteria with special reference toBacteroides fragilis. Scandinavian Journal of Infectious Diseases 1979, 19: 17–25.
Goffic, F. L. Structure activity relationships in lincosamide and streptogramin antibiotics. Journal of Antimicrobial Chemotherapy 1985, 16, Supplement A: 13–21.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nord, C.E., Lindmark, A. & Persson, I. Susceptibility of anaerobic bacteria to the new streptogramin RP 59500 in vitro. Eur. J. Clin. Microbiol. Infect. Dis. 8, 1064–1067 (1989). https://doi.org/10.1007/BF01975171
Issue Date:
DOI: https://doi.org/10.1007/BF01975171